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Abstract
A model of murine toxoplasmosis was used to study cellular and temporal expression of uncoupling protein-2 (Ucp2) in the brain. In situ
hybridization indicated that Ucp2 was located in neurons. Nuclei structures involved in energy balance, in particular the nucleus of the solitary
tract (NST), was shown to have a positive association between negative energy balance and Ucp2 levels. Infection-induced Ucp2 expression
colocalized mainly with microglial cells, but also with infiltrating macrophages and neutrophils in the brain, which was evident from day 9 post-
infection. Using cytokine knockout mice we demonstrate that microglial Ucp2 induction in the brain was largely dependant on interferon-γ, but
not interleukin-6 or tumour-necrosis-factor-α in response to infection. In summary, this study shows that Ucp2 is regulated in a different manner in
neurons than in microglia/phagocytes following infection. Our study indicates that an association exists between negative energy balance and
neuronal Ucp2 levels in the NST, in particular.
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1. Introduction
Uncoupling proteins 1, 2 and 3 form a subfamily of
mitochondrial carrier proteins. Ucp1 is the archetypical
uncoupling protein. It is found in the inner membrane of the
mitochondrion, where it uncouples fuel oxidation from ATP
synthesis by dissipating the proton gradient that builds up across
the inner membrane during the transport of electrons through the
respiratory chain. In the presence of an active Ucp1, the proton
motive force is not used for ATP synthesis, but is dissipated as
heat (Nichols and Locke, 1984). In contrast to Ucp1, which is
specifically expressed in brown adipose tissue,Ucp2mRNA has
been detected in a large spectrum of mammalian tissues (Fleury
and Sanchis, 1999), where its function largely remains to be
resolved. Instead of what was initially anticipated (Fleury et al.,
1997),Ucp2 does not seem to be critical in energy balance under
normal conditions. Accordingly, studies carried out in Ucp2
knockout (KO) mice have shown that these mice exhibit a
normal thermogenic response to cold (Arsenijevic et al., 2000).
Ucp2 expressed in peripheral tissue is modulated by numerous
conditions and treatments (Argyropoulos and Harper, 2002;
Ricquier and Bouillaud, 2000) but its role is still a matter of
debate. However, it has been suggested that Ucp2 is a negative
regulator of insulin secretion in pancreatic islet by decreasing
ATP levels (Zhang et al., 2001). A study by our group also
proposed that Ucp2 may have functions in immunity and
reactive oxygen species (ROS) production (Arsenijevic et al.,
2000). When challenged with an infection, Ucp2 KO mice were
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more resistant to Toxoplasma gondii infection. This was
explained by a larger amount of ROS produced by their
macrophages and enhanced elimination of the microbe. An
important in vitro study also showed thatUcp2may be regulated
by superoxide production (Echtay et al., 2002).
In the murine brain, Ucp2 is expressed in specific regions as
well as in ventricle-associated areas, these cells being predom-
inantly neuronal populations of subcortical regions that are in-
volved in the central regulation of autonomic, endocrine, and
metabolic processes (Richard et al., 1998).Ucp2 has been studied
in pathophysiological models such as ageing (Mizuno et al.,
2000), epilepsy (Clavel et al., 2003; Diano et al., 2003; Sullivan
et al., 2003), Parkinson's disease (Andrews et al., 2005), ischemia
(de Bilbao et al., 2004; Mattiasson et al., 2003) and brain trauma
(Mattiasson et al., 2003). The currently proposed view concerning
Ucp2 action is that it may act as a sensor of the redox state and
may then decrease subsequent ROS production. However, it is
important to acknowledge that brain degenerative processes are
also generally accompanied by the activation of the innate im-
mune system represented by activated astrocytic and phagocytic
microglial cells. This activation may also be involved in driving
the Ucp2 expression. Interestingly, cytokines and lipopolysac-
charide (LPS) injections are well known to alterUcp2 in a variety
of tissues (Busquets et al., 2001; Cortez-Pinto et al., 1998;
Faggioni et al., 1998; Masaki et al., 1999; Yu et al., 2000)
including the brain. Proposed functions for the Ucp2 following
acute immune challenge include the increased in energy expen-
diture and a role in protecting cells against oxidative stress.
Toxoplasmosis affecting the central nervous system is now
one of the leading causes of death among AIDS patients
(Holliman and Greig, 1997). T. gondii is an obligate
intracellular parasite capable of infecting nearly all warm-
blooded animals. We initially used this infection because this
parasite greatly affects energy balance and induces phases
specific for hypermetabolism and anorexia in mice in a well
characterized fashion (Arsenijevic et al., 1997). Parasite cysts
formation is common in the brain during the course of
toxoplasmosis where cellular immune responses are restricted
due to the blood brain barrier and low expression of the major
histocompatibility complex antigens (Daubener and Hadding,
1997). Brain inflammation in the chronic phase of infection is
caused by rupture of cysts. The earlier part of the infection (day
9 and onward) is accompanied by immune cell infiltration of the
brain by macrophages, monocytes, neutrophils, B cells, CD4+
and CD8+ T cells. Moreover, the main defence against T. gondii
is mediated by natural killer (NK), T-cells and macrophages.
The NK and T-cells produced IFN-γ, which is a major
component involved in the defence against T. gondii in brain
tissue (Chao et al., 1993; Yap and Sher, 1999). Macrophages
and lymphocytes also produced interleukin-6 (IL-6) or tumor-
necrosis-factor-α (TNF-α), which are involved in the immune
responses against this parasite (Daubener and Hadding, 1997).
In a previous study, we studied the immune defense and ROS
production of Ucp2 KO mice to T. gondii infection. However,
the role of immune cells and their cytokines in driving Ucp2
expression regulation, following infection, is still unknown. In
order to study the brain regulation of Ucp2, the objectives of the
present study were (i) to identify cells expressing Ucp2 before
and after infection in order to assess the effect of infection on
Ucp2 in brain cell subgroups such as neurons and microglia,
(ii) to determine if Ucp2 may be associated with negative
energy balance observed following infection by studying Ucp2
expression in a few nuclei involved in energy balance — the
area postrema (AP), nucleus solitary tract (NST), ventrome-
dial hypothalamic nucleus (VMH) and arcuate nucleus (ARC),
(iii) to delineate the role of immune cells infiltration in driving
Ucp2 expression by investigating the temporal and associated
cellular expression of this gene in both acute and chronic phases
of the T. gondii infection and (iv) to examine whether cytokines
such as TNF-α, interferon -γ (IFN-γ) and IL-6, induced in the
course ofT. gondii infection, may be involved inUcp2 regulation.
2. Materials and methods
2.1. Animals and treatment
Male Swiss Webster (CFW) mice (Charles River, Canada) of
4–6 weeks of age were used for all the experiments. Cytokine
deficient mice used were IFN-γ KO (BALB/c-Ifngtm1Ts), TNF-α
KO (C57BL/6-TNFtm1Gkl) and IL-6 KO (C57BL/6J-IL6tm1kopf)
(Jackson Laboratories, Bar Harbour, ME,USA). The mice were
housed individually in polycarbonate cages, kept at room tem-
perature with a 12:12 h light dark cycle and had free access to tap
water and standard laboratory chow diet. Mice were injected
intraperitoneally with 10 cysts of the Me49 strain of T. gondii
(obtained fromDr L.L. Johnson, Trudeau Institute, Saranac Lake,
NY, USA) and the brains were collected. All mice were cared for
and handled according to the Canadian guide for the Care andUse
of LaboratoryAnimals. The present protocolwas approved by our
institutional animal care committee.
2.2. Northern blot
Mice which were chronically infected for 28 days and which
comprise Gainers (G), Non-Gainers (NG) and non-infected
controls (n=3 per group) were used to determine central Ucp2
mRNA. Mice were deeply anesthetized with 0.3–0.5 ml of a
mixture containing 40 mg/ml of ketamine and 2 mg/ml
xylazine. Without delay they were intracardially perfused with
ice-cold isotonic saline. At the end of the perfusion the whole
brains were quickly dissected out and frozen. Total RNA was
prepared as described before (Chomczynski and Sacchi, 1987).
Northern blot analyses were performed using the mouse Ucp2
cDNA labeled with 32P under standard conditions. Similar
amount of total RNA (20 μg) was used in every lane.
2.3. In situ hybridization histochemistry
In situ hybridization histochemistry was used to localize
Ucp2 mRNA on tissue sections taken from the olfactory bulb to
the brainstem in non-infected control mice and infected mice on
days 1, 3, 9, 14 and 28 post-infection. Note that on day 28 after
infection mice consist of 2 subgroups the G and NG. The
protocol used was largely adapted from that described by
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Simmons (Simmons et al., 1989). Briefly, one out of every 5
brain sections were mounted on to poly-L-lysine coated slides
and allowed to desiccate overnight under vacuum. The sections
were then successively fixed for 20 min in paraformaldehyde
(4%), digested for 30 min at 37 °C with proteinase K (10 μg/ml
in 100 mM Tris–HCl containing 50 mM EDTA, pH 8),
acetylated with acetic anhydride (0.25% in 0.1 M trietholamine,
pH 8) and dehydrated through graded concentrations (50, 70, 95
and 100%) of alcohol. After vacuum drying for at least 2 h,
90 μl of hybridization mixture, which contains an antisense 35S
labeled cRNA probe (10 million cpm/ml), were spotted on each
slide. The slides were sealed under a coverslip and incubated
overnight at 60 °C in a slide warmer. The next day, the cover
slips were removed and the slides rinsed four times with 4X
SSC (0.6 M NaCl, 60 mM sodium citrate buffer, pH 7). They
were digested for 30 min at 37 °C with RNAse A (20 μg/ml in
10 mM Tris–500 mM NaCl containing 1 mM EDTA, washed in
descending concentrations of SSC (2×, 10 min; 1×, 5 min; 0.5×,
5 min; 0.1×, 30 min at 60 °C), and dehydrated through graded
concentrations of alcohol. After a 2-hour period of vacuum
drying, the slides were exposed on an X-ray film (Eastman
Kodak, Rochester, NY) for 24 h. Once removed from the
autoradiography cassettes, the slides were defatted in xylene
and dipped in NTB2 nuclear emulsion (Eastman Kodak). They
were exposed for 7 days, before being developed in D19
developer (Eastman Kodak) for 3.5 min at 15 °C and fixed in
rapid fixer (Eastman Kodak) for 5 min. Finally tissues were
rinsed in running distilled water for 1 to 2 h, counterstained with
thionin (0.25%), dehydrated through graded concentrations of
alcohol, cleared in xylene and coverslipped with DPX.
2.4. Antisense (35S)-labeled cRNA probes
The Ucp2 cRNA probe was generated from the 945 bp
EcoR1 fragment of a mouse Ucp2 cDNA subcloned into a
pSELECT vector (Promega Inc., Lyon, France), which was
linearized with SacI and KnpI (Pharmacia Biotech Canada,
Inc., Baie d'Urfè (Qc), Canada) for sense and antisense probes,
respectively. The radioactive riboprobes were synthesized by
incubating 250 ng of the linearized plasmid into a solution
containing 10 mM NaCl, 10 mM dithiothreitol, 6 mM MgCl,
40 mM Tris (pH 7.9), 0.2 M ATP/GTP/CTP, alpha (35S)-UTP,
40 U RNasin (Promega, Madison, WI) and 20 U SP6 and T7
RNA polymerase for sense and antisense probes, respectively,
for 60 min at 37 °C. The DNA templates were treated with
100 ml of a DNAse solution (1 ml DNAse, 5 ml of 5 mg/ml
tRNA and 94 ml of 10 mM Tris/10 mM MgCl2). The
preparation of the riboprobes was completed through a
phenol-chloroform extraction and ammonium acetate precipi-
tation. The specificity of the antisense riboprobe was confirmed
by the absence of a positive signal in brain sections hybridized
with the sense probe (not shown).
2.5. Combination of immunohistochemistry with in situ
hybridization
Immunocytochemistry was combined with in situ hybridiza-
tion histochemistry to determine the phenotype of the cells that
express Ucp2 mRNA in the mouse brain after infection of
T. gondii on days 1, 3, 9, 14 and 28 post-infection. The following
antibodies were obtained from Cedarlane (Hornby, Ontario,
Canada) unless otherwise stated and were used to detect sub-
types of immune cells: macrophage–monocytes and microglial
cells were stained using the anti-F4/80 antibody (1:500),
microglial cells by the antibody directed against Iba-1 molecule
(1:500, gratefully provided by Dr. Yoshinori Imai); anti-
neutrophils (1: 500); natural killer cells with the anti-asialo
GM1 antibody (1:500); B cells by pan B cell marker CD45R Ly5
antibody (1:2500); leukocyte common antigen CD45 (1:500); T-
cell subset by CD4 (1 :100) and CD8 (1 :100) antibodies; and
endothelial cells were stained using von Willabrandt factor
(1:30000). Astrocytes were stained using the mouse anti-glial
fibrillary acidic protein antibody, purchased at Chemicon
International Inc. (CA, USA) (1:1200). Brain sections were
Fig. 1. A, Body weight in mice infected (i.p.) with 10 cysts of Toxoplasma
gondii (Me49 strain). Values are presented as mean±SEM for the various group
(n=6), and abbreviated as follows: G = Gainers and NG = Non-Gainers.
⁎Indicates a significant difference when compared to Control group (pb0.01).
#Indicated a significant difference when comparing NG to G (pb0.05).
Fig. 2. Northern blot analysis of Ucp2 mRNAs in the brain of controls, infected
Non-Gainers and infected Gainers mice. A, Top panel, an autoradiograph with
uncoupling protein 2 mRNA is shown. Bottom panel, constitutively expressed
RNA (18S) on the same blot. B, PhosphorImage data, Ucp2 signal was
normalized for 18S RNA expression in the same sample. Results are mean S.E.,
n=3, ⁎pb0.001 NG and G vs controls.
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first processed for immunocytochemical detection of one of the
previous antibodies using a conventional avidin–biotin–immu-
noperoxidasemethod. Briefly, brain slices were washed in sterile
50 mM potassium PBS (KPBS) that was treated with
diethylprocarbonate water. They were then incubated overnight
at 4 °C with one of the previous mentioned antibodies in KPBS
(50 mM) with heparin (0.25%), Triton X-100 (0.4%) and BSA
(2%). Following incubation at 4 °C with the first antibody, the
brain slices were rinsed in sterile KPBS and incubated with a
mixture of KPBS, Triton X-100, heparin, a biotinylated
Fig. 3. Rostrocaudal distribution of Ucp2 mRNA in the mouse brain under basal condition and following an i.p. injection with 10 cysts of the Me49 strain of
Toxoplasma gondii in the brain of Swiss Webster mice. Animals were killed 3, 9 and 28 days after i.p. infection. These rostrocaudal sections (Scale bar: 25 μm)
exhibit a positive signal on X-ray film on various structures of the brain. The pictures represent the X-ray film autoradiograms of coronal brain sections representative
of the group (N=4) that were hybridized with an antisense riboprobe complementary to mouseUcp2mRNA. Each presented section approximately corresponds to the
same rostrocaudal level for the groups, which allows the comparison within distribution.
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rinsed with KPBS and incubated at room temperature for 60 min
with an avidin–biotin–peroxidase complex (Vectasain ABC
Elite Kit; Vector labs., Burlingame, CA). After several rinses in
sterile KPBS, the brain slices were allowed to react in a mixture
containing sterile KPBS, the chromagen 3,3′-diaminbenzidine
tetrahydrochloride (DAB, 0.05%) and 1% hydrogen peroxide.
Thereafter, tissues were rinsed in sterile KPBS, mounted onto
poly-L-lysine-coated slides, dessicated overnight under vacuum,
fixed in paraformaldehyde (4%) for 3 min, and digested for
30 min at 37 °C with proteinase K (10 mg ml in 100 mM Tris
HCL, pH 8.0, and 50 mM EDTA). Pre-hybridization, hybrid-
ization, and post-hybridization steps were performed as
described above except for the dehydration step, which was
shortened to avoid decolorization. After vacuum drying for 2 h,
sections were exposed on X-ray film, defatted in xylene, and
dipped in the NTB2 nuclear emulsion. Slides were exposed for
7 days, developed in D19 developer for 3.5 min at 15 °C, and
fixed in rapid fixer for 5 min. Thereafter, tissues were rinsed in
running distilled water for 1–2 h, rapidly dehydrated through
graded concentrations of alcohol, cleared in xylene, and
coverslipped with DPX.
3. Results
3.1. Body weight, food intake and energy expenditure following
infection
Fig. 1 illustrates the body weight changes following
infection. We previously characterized our model (data not
shown, Arsenijevic et al., 1997) and showed that all infected
mice were hypermetabolic from day 1 following the infection.
After 7–14 days, all mice exhibited a weight loss, which was
associated with anorexia and hypermetabolism. After day 14,
mice started to stabilize their body weight and food intake.
Subsequently, the infected mice were classified as ‘Gainers’ (G)
if they showed a regain in body weight after infection-induced
cachexia or ‘Non-Gainers’ (NG) if they showed no regain after
the acute phase of infection. In the chronic phase on day 28, the
NG remained hypermetabolic and anorexic, while G were not
hypermetabolic but anorexic. Both G and NG maintained stable
body weight and food intake in the chronic phase of infection.
3.2. Ucp2 expression following infection detected by Northern
blot
Fig. 2 illustrates Northern blot analysis showing the Ucp2
expression in the mouse brain following infection with T. gondii.
Total RNA extracts were obtained from control mice, infected G
at day 28 and infected NG at day 28. Ucp2 mRNAwas normal-
ized to 18 S. Chronic infection with T. gondii led to a significant
increase in the Ucp2 expression (respectively, 240% and 410%
for G and NG, pb0,001, n=3).
We have tried different antibodies against brain Ucp2 but
none proved to be suitable as we and our collaborators (Pecqueur
et al., 2001) and others (Nishio et al., 2005) have shown that
antibodies toUcp2 protein reacts in a tissue specific manner. No
suitable antibody was found for brain Ucp2 as they either gave
more than one band or could not be detected by Western blot
from brain extracts. Therefore we could not do any double
labeling experiments with Ucp2 protein. However, a role for
Ucp2 in brain neuroprotection has been shown using Ucp2
transgenic mice (Mattiasson et al., 2003) andUcp2KOmice (de
Bilbao et al., 2004). In addition, Ucp2 KO mice have altered
appetite control following MCAO (Arsenijevic et al., 2006). A
transgenic Ucp2 mouse strain has also been shown to modify
NPY brain levels associated with increased food intake (Horvath
et al., 2003).
3.3. Distribution of Ucp2 mRNA throughout the brain of mice
chronically infected with T. gondii
To determine in which nuclei the expression of Ucp2 was
enhanced, we used in situ hybridization on brain from mice at
different times following the infection. The rostrocaudal distri-
bution of Ucp2 mRNA in the brains of control mice and of mice
after 3, 9, and 28 (NG and G) days post-infection is illustrated in
Fig. 3. Under basal conditions, the expression ofUcp2was found
in several regions of the brain. The hybridization signal was
strong in hypothalamic nuclei that include the median preoptic
nucleus, suprachiasmatic nucleus, paraventricular hypothalamic
nucleus, ARC, VMH, and dorsomedial hypothalamic nucleus.
Also, others regions of the forebrain such as the septal region,
amygdala and thalamus all expressed significant levels of Ucp2
mRNA. In the thalamus, the expression was especially strong in
the submedius thalamic nucleus [for a complete distribution, see
(Richard et al., 1998)].
The distribution of the Ucp2 transcript in the brain did not
significantly change during the first three days following the
infection with T. gondii (Day 1, data not shown). However, on
day 9 and in the chronic stages of the infection, Ucp2
expression augmented compared to controls. Also, the distri-
bution of Ucp2 was markedly different in infected mice
Fig. 4. Ucp2 expression in the area postrema (AP), nucleus solitary tract (NST),
ventromedial hypothalamus nuclei (VMH) and arcuate nucleus (ARC) on days
3, 9 and 28 after Toxoplasma gondii infection, note that on day 28 infected mice
consist of two subgroups the Gainer (G) and the Non-Gainers (NG). The levels
of Ucp2 mRNA was determined as described in the methods section on brain
slices by densitometry scans on the respective nuclei, N=4 mice per group. Note
that “a” indicates that there was a significant difference (pb0.001) when
compared to the control group, ⁎ indicates that there is a significant difference
(pb0.001) comparing the NG to G group.
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compared to non-infected controls. Infection resulted in the
presence of many areas giving a high signal and this was not
associated with a given neuronal loci unlike what is
characteristically seen in control mice (Fig. 3). Infection
induced labeling that was associated with immune cell
infiltration and the labeling also appeared around blood vessels.
The parasite load in the brain of G is less than in NG and is
associated with a higher immune activation in the latter group
(Arsenijevic et al., 1997). Concerning the intact cyst, we did not
observe any co-association with Ucp2 mRNA induced
expression and inflammation loci, since most of the cysts
were in neurons. The expression of Ucp2 was associated with
microglia and/or infiltrating immune cells, the later being
believed to accumulate in response to the rupture of cysts
(Frenkel and Escajadillo, 1987). We did not observed that there
was a specific brain site associated with cysts and/or
inflammatory loci in the G or NG as cysts location and in-
flammatory loci appeared to be random. We did not found
histological evidence for a link between inflammatory cells or
cysts and specific regions involved in energy balance
(hypothalamus or brain stem). The effect of infection and
inflammation on neuronal energy balance centers therefore did
not appear to be site specific.
We studied the mRNA levels of Ucp2 in the AP, NST, ARC
and VMH as examples of nuclei known to be involved in energy
balance on day 3, 9 and 28 (for the latter in G and NG
subgroups). As it can be seen from the results in Fig. 4,
significant changes occurred in Ucp2 levels in these areas after
Fig. 5. Brightfield photomicrographs showing the type of cells expressing Ucp2 mRNA in mice chronically infected with Toxoplasma gondii in the cerebral cortex,
although inflammation was generalized throughout the brain. Neutrophils were labeled by immunocytochemistry using an anti-neutrophils antibody (upper panel),
macrophages–monocytes cells were detected using F480 antibody (middle panel), while cells of myeloid origin were detected using an antibody directed against the
iba1 molecule (lower panel).Ucp2mRNAwas revealed by silver grains in cells, also note that in the different antibody stained immune cells sections there are areas of
non-colored intense silver grains these are microglia. Microglial cells represent the majority of cells that were colocalized with Ucp2 in the chronic phase of infection
and are indicated by arrows in neutrophil and macrophage stain sections. Scale bar 7 μm.
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infection. In particular, Ucp2 in the AP and VMH was initially
reduced following infection and then there was a gradual return
near control levels in the NG only after 28 days of infection. In
the NST, infection results in increases in Ucp2, which was
maintained at significantly higher levels over the whole period
of infection. In the ARC Ucp2 was markedly reduced on day 9
after infection but in the early and later phases of infection it
was similar to control levels.
3.4. Immune cells expression and double labeling with Ucp2
To characterize the immune cells infiltration time course and
to verify which cell type expresses Ucp2, we used a double
labeling procedure. During the first 3 days of infection, no
lymphocyte of the CD45, CD45R, CD4 or CD8 subgroups,
neutrophil, nor macrophages where seen in the brain. At the
same time, the brain microglial cells were activated, as
evidenced by F4/80 staining and reconfirmed with Iba staining,
but this was not associated with the induction of Ucp2 in the
those cells (data not shown). Progression of the infection
resulted in an increase in Ucp2 mRNA. This was associated
with increased lymphocyte invasion in blood vessels, ventricle
spaces and brain tissue. Immunohistochemistry and double
labeling with Ucp2 identified neutrophils (Fig. 5, upper panel)
and macrophages (Fig. 5, middle panel) to be the main cells to
infiltrate the brain parenchyma where Ucp2 expression was
increased at day 14. Further colocalization with mRNA and cell
type revealed that most of the Ucp2 was associated with
activated microglial cells in brain inflammation sights (Fig. 5,
lower panel). Macrophages also expressed Ucp2 in high
quantities but appeared less frequent than microglial cells in
brain tissue. However, they were the major source of Ucp2 in
Fig. 6.Ucp2 in situ hybridization (black spots) and immunostained microglia with iba1 (brown colored cell indicated with arrow) in wild-type (WT) and infectedUcp2
KO mice, this shows that microglia are still present in the Ucp2 KO brain (upper 2 panels). Ucp2 in situ hybridization in infected wild-type (WT) and infected Ucp2
KO mice (middle 2 panels) shows that in the brain of WT immune infiltrate inflammation loci there labeling of Ucp2, in marked contrast the immune infiltrates in
Ucp2 KO mice show no labeling. Morphological identification of infiltrating immune cells, neutrophils (PMN) are identified by their multi-lobed nuclei (arrow) and
macrophage by their bean shaped nuclei (arrow), brain slices were stained with haemotoxylin and eosin. Scale bar7 μm.
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ventricular space and in blood vessels (Fig. 5, middle panel).
Blood vessel endothelial cells as identified with von Will-
abrandt Factor (vWF) showed variable expression of Ucp2. In
fact, not all vWF positive blood vessels express Ucp2 (not
shown). Blood vessels in control animals were not observed to
have elevated Ucp2. The variable expressions suggest differ-
ential activation or infiltration of other Ucp2 positive cells.
There was an association with immunocytochemical labeled
neutrophils (Fig. 5, upper panel) and no association with natural
killer cells, CD45R, CD45, CD8+ and CD4+ T cells (data not
shown).
Ucp2 colocalization with microglial cells at day 9 and
onward was surprising since activated microglial cells were
found in the first days after infection but were not associated
with an increased Ucp2 expression. However, one important
factor at day 9, which could have led to the induction of Ucp2
was the invasion of immune cells in the areas of increased Ucp2
expression and microglial activated cells. This suggests that
immune cells (phagocytes and lymphocytes) may produce
factors that are required for Ucp2 induction. We show that
Ucp2 KO mice have microglia and the lack of Ucp2 induction
in these mice cannot be explained by the lack of these cells in
the brain (Fig. 6). Neutrophils, macrophage/monocytes and
lymphocytes were not detected in the brains of non-infected
controls and are therefore control slides are not shown. We
show that immune infiltrates in wild-type mice show Ucp2
staining where as brain immune cell infiltrates in Ucp2 KO
mice do not (Fig. 6). Immune cell infiltration morphological
identification (neutrophils, macrophage/monocytes, lympho-
cytes) and colocalization with Ucp2 (silver grains) was also
carried out with histochemical staining with haematoxylin–
eosin staining (Fig. 6).
3.5. Central Ucp2 expression in IL-6 KO, TNF-α KO and IFN-γ
KO mice
Since T. gondii infection is associated with increased
cytokines levels, we have used gene knockout mice for IL-6,
TNF-α and IFN-γ in order to examine the role of these
important cytokines in toxoplasmosis and the expression of
Ucp2 in microglia. We chose those three cytokines because they
are the in the brain of chronically infected mice and are
produced by macrophages and/or lymphocytes. Toxoplasmosis
results in an increase expression of Ucp2 compared to saline-
Fig. 7. Central Ucp2 expression in IL-6 KO, TNF-α KO and IFN-γ KO mice at day 9 following Toxoplasma gondii infection. The pictures represent the X-ray film
autoradiograms of coronal brain sections that were hybridized with an antisense riboprobe complementary to mouse Ucp2 mRNA. Each presented section
approximately corresponds to the same rostrocaudal level, which allows the comparison between mice. Sections are representative of the expression obtained in each
animals of a given group. Note the absence of enhanced Ucp2 expression in IFN-γ KO mice as compared to the IL-6 KO and TNF-α KO mice (black arrows).
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injected controls in the IL-6 KO and TNF-α KO mice 9 days
after treatment (Fig. 7 middle panels). However, in the IFN-γ
KO mice, enhanced microglial Ucp2 expression was not
observed following 9 days of infection (Fig. 7, lower panel).
This suggests that IFN-γ is an important factor in the Ucp2
induction following toxoplasmosis in microglia.
4. Discussion
The present study demonstrates that global brain Ucp2
expression is enhanced during chronic toxoplasmosis as
measured by northern blot. This observation was confirmed
by in situ hybridization and this method allowed us to show that
the distribution of Ucp2 was markedly altered following
infection. We observed a shift in the cellular sites of expression
of Ucp2, initially from neurons to blood vessels and cellular
inflammation clusters. In the acute phase, there was no
difference in the cellular pattern of Ucp2 expression compared
to non-infected controls; it was in neurons and in cells lining the
brain. From day 9 post-infection, we found that Ucp2
colocalizes along with macrophages/monocytes and neutrophils
that had infiltrated into brain tissue. However, a certain
proportion of Ucp2 mRNA from this time on was associated
with activated microglia as indicated by F4/80 staining. This
finding is somewhat surprising since activated microglial cells
were detected 3 days after infection but there was no associated
increase inUcp2 expression. One significant difference between
early microglia on day 1 and 3 post-infection compared to day 9
is the presence of brain immune cell infiltration, in particular
lymphocytes and blood phagocytes in areas of microglial
activated cells with increased Ucp2 expression at the later time
point. This suggests that Ucp2 in microglial cells cannot be
directly induced by factors released from other microglial cells,
astrocytes, neurons and brain blood vessel cells but require the
presence immune cells (lymphocytes, macrophage, neutrophils)
or substances released by these cells to induce microglial Ucp2
in this model.
We also demonstrate for the first time that Ucp2 is expressed
at high levels in neutrophils. This is of particular importance
since neutrophils are considered to be the phagocytes that
produce the most ROS by the NADPH oxidase when they come
into contact with foreign agents or during infection. Neutrophils
are known to usually have a low number of mitochondria and
this may be due to the high amounts of ROS that these cells are
potentially capable of producing, which could in turn be toxic to
mitochondria (Fossati et al., 2003).
ROS may originate from many different sources including
mitochondria, peroxisomes, microsomes and by oxidases, and
the importance of these sources may vary depending whether it
is under basal conditions or during a stress or an inflammatory
process (Droge, 2002; Fang et al., 2002). In particular during
inflammation or infection, cells such as neutrophils, macro-
phages, microglia and other phagocytes, which are important in
innate defenses, can produce a lot of ROS by the NADPH
oxidase system (Victor et al., 2004) to eliminate microbes.
Macrophages are capable of increasing Ucp2 in relation to their
capacity for respiratory burst (Nishio et al., 2005). The Nishio
study implies that Ucp2 is strongly associated with the cells
capacity to produce ROS and therefore supports a role for Ucp2
as an anti-ROS regulator. A role for Ucp2 to regulate NADPH
oxidase at least at the protein level does not appear to be a
mechanism (Nishio et al., 2005; Bai et al., 2005). Ucp2
regulation of ROS could be due to altering ATP, NADPH and
GSH levels, this could determine the redox state of a cell and its
organelles (i.e. mitochondria). ATP, NADPH, GSH are linked
by the synthesis of GSH an important anti-oxidant which can
determine ROS levels (Li, 1999). Ucp2's proposed role is to
protect mitochondria from ROS since these organelles are vital
for cell survival (Gibson and Huang, 2004). However the
importance of mitochondrial ROS vs NADPH oxidase ROS in
an anti-toxoplasmic activity must take into account that T. gondii
has been show to have a close association with the host mito-
chondria (Sinai et al., 1997).
Evidence suggests that Ucp2 could limit the production of
ROS (Arsenijevic et al., 2000; Negre-Salvayre et al., 1997;
Nicholls and Budd, 2000; Richard et al., 1998; Skulachev,
1998). Since macrophages and microglia can secrete ROS, it is
plausible that the Ucp2 over-expression in these cells may
protect cells from free radical damage in the lesion sites.
Accordingly, we recently showed that macrophages from Ucp2
KO mice produce more ROS than wild-type mice, emphasizing
a role for Ucp2 in ROS production in phagocytes (Arsenijevic
et al., 2000). Taking into account the temporal induction of
Ucp2 in brain microglial cells, this induction is probably not
directly due to a general increase in oxidative stress but a
specific local production, since it was shown that reactive
oxygen species and lipid peroxidation already occurs by day 1
post-infection (Arsenijevic et al., 2001). However, ROS may
indirectly activate Ucp2 expression by depleting or inactivating
some anti-oxidant systems (de Bilbao et al., 2004) and it is
known that redox state can regulate gene expression. The anti-
oxidant state of the cell or mitochondria in particular may
regulate Ucp2. In a recent study using a murine model of
cerebral ischemia, Ucp2 was induced to a maximal levels only
when mitochondrial glutathione was depleted and it may act as
a GSH transporter (de Bilbao et al., 2004; Fernandez-Checa and
Kaplowitz, 2005).
Cytokines are important regulators of ROS and in particular
IFN-γ. In our model, the induction of Ucp2 in the microglia
seems to be largely dependent on IFN-γ since the IFN-γ KO
mice did not exhibit any enhanced expression in the
parenchyma. The increased induction of Ucp2 mRNA in
microglia does not seem to be regulated by IL-6 or TNF-α
because the respective KO mice showed an increase Ucp2
response to infection. Our result with TNF-α is in contrast to
what has been observed in peripheral tissues such as liver
(Cortez-Pinto et al., 1998; Faggioni et al., 1998), muscle
(Busquets et al., 1998; Faggioni et al., 1998), white adipose
tissue (Faggioni et al., 1998) and heart (Noma et al., 2001)
where TNF-α induced Ucp2 expression. However, our finding
is consistent with another study showing that the effect of an
acute treatment of LPS on the Ucp2 expression in the brain was
not mediated by TNF-α (Busquets et al., 2001). This suggests
that TNF-α may have an indirect effect on Ucp2 induction
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depending on the tissue or cell involved in Ucp2 expression. It
should be remembered that TNF-α is also capable of acutely
upregulating IFN-γ (Car et al., 1994) so some of the observed
effects of TNF-α may be due to cytokines it induces.
Our findings support previous studies in that the induction of
Ucp2 occurs in different tissues following immune activation
(Busquets et al., 2001; Cortez-Pinto et al., 1998; Faggioni et al.,
1998; Lee et al., 1999; Masaki et al., 1999; Yu et al., 2000). These
results are consistent with the proposition thatUcp2 upregulation
by LPS and other cytokines reported using Northern blots may in
part be regulated by immune cell infiltration (Busquets et al.,
2001; Faggioni et al., 1998; Yu et al., 2000). Recent studies by our
group have demonstrated that Ucp2 gene expression can be
induced in neuronal as well as in microglial cells following
exposure to kainic acid or in cerebral ischemia (Clavel et al., 2003;
de Bilbao et al., 2004). It should be noted that the kainic acid-
induced Ucp2 does not involve infiltrating immune cells. This
suggests that different factors regulate Ucp2 in different cell
types. We further show that following toxoplasmosis, Ucp2
regulation in neurons differs from that in microglia.
Our study also demonstrates that Ucp2 is markedly
decreased in the AP and the VMH whereas it is increased in
the NST on day three post-infection. This indicates that
neuronal Ucp2 changes can occur in the absence of immune
cell infiltration in the CNS unlike microglia. It is not known
whether the modified neuronal Ucp2 expression is due to
factors external or internal to the brain. It should be noted that in
our model there is an increase in the oxidative stress in the brain
following infection before the observed immune cell infiltration
and it may be this oxidative stress that alters Ucp2 (Arsenijevic
et al., 2001).
The major role proposed for Ucp2 has been that it regulates
ROS production (Negre-Salvayre et al., 1997; Arsenijevic et al.,
2000), however other studies suggest that it may regulate insulin
secretion (Kassis et al., 2001; Zhang et al., 2001). T. gondii
infection results in induction of Ucp2 mRNA in the chronic
phase of infection in various tissues (muscle, white adipose
tissue, brown adipose tissue, pancreas — data not shown). The
observed increased pancreatic Ucp2 in infected mice was
associated with a decrease in plasma insulin levels in
chronically infected mice (Picard et al., 2002). This is consistent
with other studies suggesting that Ucp2 is a negative regulator
of insulin secretion (Zhang et al., 2001).
There is evidence of Ucp2 chromosomal location with
genetic linkage to obesity (Fleury et al., 1997). Initial studies
with Ucp2 KO mice did not show evidence that there was food
intake or energy expenditure differences between KO and WT
mice under basal conditions (Arsenijevic et al., 2000). However
complementary adaptation may have occurred in the KO mice,
since food intake regulation and energy expenditure are
regulated in a composite nature. For example following cerebral
ischemia Ucp2 KO mice have compensated activation of anti-
oxidant mechanisms in the basal state prior to brain injury (de
Bilbao et al., 2004). We have shown that Ucp2 KO mice have
altered food intake responses following cerebral ischemia with
an implication of neuropeptide Y (NPY) (Arsenijevic et al.,
2006). Ucp2 transgenic mice have increased food intake and
this was associated also with NPY levels (Horvath et al., 2003).
Furthermore Ucp2 is found in areas where NPY has been
localized (Lin et al., 2006; Glass et al., 2002). NPY may also
influence other homeostasis mechanisms apart from food intake
such as corticosterone, thyroid status and other neuroendocrine
hormones (Harfstrand, 1987). In particular corticosterone and
thyroid hormones are altered in toxoplasmosis (Picard et al.,
2002; Stahl and Kaneda, 1998). Toxoplasmosis results in
cachexia and a possible role for the VMH is suggested since this
brain site is involved in catabolic responses (Uyama et al.,
2004). One would expect differences in nuclei activation
between G and NG since G are hypophagic whereas NG are
hypophagic and hypermetabolic. Our finding of altered Ucp2
mRNA levels in neurons suggest when integrating the above
information that Ucp2 may regulate energy balance pathways.
Our study indicates that Ucp2 may do more than just regulate
ROS.
The association of Ucp2 in the NST and the degree of body
weight loss also supports the notion that Ucp2 in neurons may
be involved in energy food intake responses following central
inflammation (Arsenijevic et al., 2006). If Ucp2 was only
regulating ROS then one would expect that neuronal Ucp2
would increase rather than decrease after infection. Furthermore
one would not expect Ucp2 in one group of neurons to increase
while it decreases in another group at the same time after
infection. This study suggests that Ucp2 may have other
functions than ROS regulation. It may be involved in energy
balance via a cell-specific neuronal regulation. Further studies
of Ucp2 in neurons involved in energy balance are required to
elucidate whether Ucp2 alters neuronal energy balance
homeostatic pathway signalling as this study suggests.
5. Conclusions
Using our model of murine toxoplasmosis we were able to
demonstrate that Ucp2 mRNA regulation is a complex process
in the brain following infection. Our study suggests that Ucp2
mRNA is regulated in a different manner in neurons than in
brain phagocytes. The former do not appear to require presence
of infiltrating immune cells whereas the latter do. Increased
Ucp2 levels are associated with negative energy balance. We
show that Ucp2 expression in certain nuclei associated with
energy balance such as the NTS follow changes in energy
balance following infections whereas other nuclei do not. The
case for NTS Ucp2 nuclei regulating energy balance is
implicated by a temporal association, this further supports our
previous data that Ucp2 is implicated in energy balance during
inflammation (Arsenijevic et al., 2006). Due to the unexpected
increase or decrease in different nuclei at the same moment in
time we conclude that Ucp2 may not only directly be regulating
oxidative stress. Ucp2 may regulate cell function by oxidative
stress sensing which may involve changes in mitochondrial
glutathione levels as we have previously suggested. In
particular for future studies it would be interesting to study
the changes of Ucp2 and their association with changes in
expression of neuropeptides in these different nuclei involve in
neuroendocrine regulation of homeostasis.
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